OncLive | Bringing the Global Oncology Community Together

Education ▼

Conference Coverage

NewsNetwork

OncLive TV

PEER EXCHANGE

OncLive INSIGHTS

Stay tuned for our LIVE OncLive News Network coverage straight from the #ASH18 conference floor!

SPECIALTY TOPICS

CURRENTLY VIEWING
All Specialties

Gastrointestinal Cancer

Latest News

Adjuvant Options Expand in HER2+ Breast Cancer, But Questions Remain

Vik Gorantla, MD, discusses ongoing developments in the adjuvant setting for patients with HER2-positive breast cancer. Read More >>

Cabozantinib Approved in Europe for Second-Line HCC

FDA Grants Brentuximab Vedotin Breakthrough Designation for Frontline CD30+ PTCL

Expert Explains Treatment Approaches for MCL

Addressing De-Escalation of Treatment in HER2+ Breast Cancer

Novel Targeted Agents Emerging in Ovarian Cancer

View More Stories >>

View Conference Coverage

2018 Chemotherapy Foundation Symposium

2018 New York Lung Cancers Symposium

2018 State of the Science Summit on Hematologic Malignancies in Clayton

State of the Science Summit on GI Cancers in Newport Beach

2018 ESMO Congress

Dr. Makker on Combination Approaches in Endometrial Cancer

Dr. Benson on the Clinical Utility of cfDNA in Colorectal Cancer

Dr. Upadhyaya on the Importance of Long-Term Follow-Up in Pediatric Patients With Ependymoma

Dr. Bradley on Exercise in Treatment-Related AE Management

Rationale for Pembrolizumab Plus mFOLFOX6 in Advanced CRC

Dr. Markman Discusses the Future of Treatment for Ovarian Cancer

OncLive houses thousands of videos that provide updates and information.
See more Videos

Additional Targets in NSCLC: BRAF V600E and BRAF Variants

Second Generation ALK Inhibitors in NSCLC

Practice-Changing Frontline Treatment of ALK+ NSCLC

Updates in the Treatment of ALK+ and ROS1+ NSCLC

Adjuvant TKI for Early Stage EGFR+ NSCLC

Frontline Chemo and TKI Combination in EGFR+ NSCLC

Promising EGFR Inhibitors in Development for NSCLC

OncLive houses thousands of videos that provide updates and information.
See more Videos

Future Management of Metastatic Colorectal Cancer

Emerging Therapy in Metastatic Colorectal Cancer

BEACON Trial: Triplet Therapy in BRAF V600E

Later Lines of Therapy for Metastatic Colorectal Cancer

Other I-O Approaches to Metastatic Colorectal Cancer

ReDOS Trial: Optimizing Regorafenib Dosing in metastatic Colorectal Cancer

I-O Therapy in mCRC: Ipilimumab + Nivolumab

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured

Expert Anticipates Cure in Acute Lymphoblastic Leukemia

Elias Jabbour, MD, discussed recent clinical trial results in acute lymphoblastic leukemia, the role of immunotherapy, and the biggest challenges facing the field.

View more >>>

Featured

Dr. Ramchandren on the North American Results of the ECHELON-1 Study in Hodgkin Lymphoma

Radhakrishnan Ramchandren MD, associate professor, Wayne State University School of Medicine, Barbara Ann Karmanos Cancer Institute, discusses the North American results of the ECHELON-1 study in Hodgkin lymphoma.

View more >>>

Featured Video

Immunotherapy in the Treatment of Follicular Lymphoma

Ian W. Flinn, MD, PhD; Grzegorz S. Nowakowski, MD; Loretta J. Nastoupil, MD; and Anas Younes, MD, reflect on the value of immunotherapy, immunotherapy combination strategies, and understanding the tumor microenvironment in treating follicular lymphoma.View now

FDA Approvals in Myeloma, NSCLC, and of a Biosimilar, Priority Review in Gastric Cancer, and More